Down almost 99% from all-time highs, Canopy Growth is a beaten-down cannabis stock that remains a high-risk investment in ...
The scientific review comes as Americans are increasingly turning to the plant to cope with chronic pain, sleep difficulties, ...
Research has already shown the psychedelic drug psilocybin eases depression, PTSD, and anxiety. Now researchers are working on deleting the hallucinations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback